The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106748223 10674822 3 F 2014 20160623 20141224 20160705 EXP BR-JNJFOC-20141214736 JANSSEN 0.00 A F Y 0.00000 20160705 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106748223 10674822 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 4 VIALS EVERY 2 MONTHS Y U UNKNOWN;UNKNWON 0 LYOPHILIZED POWDER
106748223 10674822 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U UNKNOWN;UNKNWON 0 LYOPHILIZED POWDER
106748223 10674822 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 2 VIALS. START EVERY 2 WEEKS, 4 WEEKS AND AFTER EVERY 8 WEEKS. START DATE 7 YEARS AGO Y U UNKNOWN;UNKNWON 0 LYOPHILIZED POWDER
106748223 10674822 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U UNKNOWN;UNKNWON 0 LYOPHILIZED POWDER
106748223 10674822 5 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U UNKNOWN;UNKNWON 0 LYOPHILIZED POWDER
106748223 10674822 6 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 2 VIALS Y U UNKNOWN;UNKNWON 103772 200 MG LYOPHILIZED POWDER
106748223 10674822 7 C CLONAZEPAM. CLONAZEPAM 1 Unknown 0 UNSPECIFIED
106748223 10674822 8 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
106748223 10674822 9 C LOSARTAN. LOSARTAN 1 Unknown 0 UNSPECIFIED
106748223 10674822 10 C ATENOLOL. ATENOLOL 1 Unknown 0 UNSPECIFIED
106748223 10674822 11 C PREDNISONE. PREDNISONE 1 Unknown 0 UNSPECIFIED
106748223 10674822 12 C CALCIUM CALCIUM 1 Unknown 0 UNSPECIFIED
106748223 10674822 13 C METHOTREXATE. METHOTREXATE 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106748223 10674822 1 Rheumatoid arthritis
106748223 10674822 2 Rheumatoid arthritis
106748223 10674822 3 Rheumatoid arthritis
106748223 10674822 4 Rheumatoid arthritis
106748223 10674822 5 Rheumatoid arthritis
106748223 10674822 6 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
106748223 10674822 HO
106748223 10674822 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106748223 10674822 Arthritis
106748223 10674822 Drug ineffective
106748223 10674822 Intervertebral disc protrusion
106748223 10674822 Lung consolidation
106748223 10674822 Memory impairment
106748223 10674822 Movement disorder
106748223 10674822 Nosocomial infection
106748223 10674822 Pain
106748223 10674822 Product packaging quantity issue
106748223 10674822 Secretion discharge
106748223 10674822 Suicide attempt
106748223 10674822 Tuberculosis
106748223 10674822 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106748223 10674822 2 20160623 0
106748223 10674822 3 2009 0
106748223 10674822 4 2014 0
106748223 10674822 5 2015 0
106748223 10674822 6 2007 0